Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
TCT 25: Seven-Year Follow-up of the PARTNER 3 Trial
Author(s): Michael J Mack Added: 5 months ago
TCT 2025 - Long-term follow-up of the PARTNER 3 trial showed no safety concerns for transcatheter aortic-valve replacement (TAVR) compared to surgical treatment of aortic stenosis (AS).Dr Michael Mack (Baylor Scott & White Heart Hospital, Plano, US) joins us to share the clinical and echocardiographic outcomes from the seven-year follow-up of the PARTNER 3 low-risk randomised trial (NCT02675114)… View more

Imaging & Diagnostics

Intervention
Prognostic Value of HF Stratification and Cardiologist Follow-Up
Author(s): Guillaume Baudry Added: 10 months ago
ESC HF 25 - Findings from a French nationwide cohort study investigating cardiologist follow-up show greater reduction in all-cause mortality associated with annual cardiology hospital visits.Dr Guillaume Baudry (University Hospital of Brabois, Nancy, FR) discusses findings from a nationwide trial investigating the prognostic value of heart failure stratification and cardiologist follow-up in… View more

Heart Failure
Inside the Data: Prof. Donal on the Tri.Fr Extended Follow-up Results
Author(s): Erwan Donal Added: 1 week ago
ACC 2026 - Two randomised trials position TriClip TEER as a transformative option in TR, delivering significant reductions in heart failure hospitalisations and supporting earlier intervention in clinical practice.Prof Erwan Donal (Hospital Pontchaillou of Rennes, Rennes, FR) joins us on-site at ACC 2026 to share the findings from two randomised trials (Tri.Fr and TRILUMINATE Pivotal)… View more

Intervention

Heart Failure
CRT 24: The ABSORB Trial
Author(s): David Power Added: 2 years ago
CRT 24 - We are joined in this short virtual interview by investigator, Dr David Power (Mount Sinai Hospital, US) to discuss the latest findings from the ABSORB trial series, revealed in 2024 at the CRT conference.ABSORB III is a prospective, randomized, single-blind, multicenter trail aiming to support the pre-market approval of the Absorb bioresorbable vascular scaffold (Abbott) for the… View more

Intervention

Vascular Disease and Surgery
Sex Difference in Relative Survival Following PCI
Author(s): Jin-Ho Choi , Jung-Min Choi , Ki-Hong Choi , et al Added: 1 year ago

Demographic

Intervention
Same-day Discharge Following PCI: A Meta-analysis of RCTs
Author(s): Ngoc Huy Nguyen , Thanh Ngoc Le , Hoai Thi Thu Nguyen , et al Added: 9 months ago

Intervention
ACC 25 Late-Breaking Discussion: The FRESH-UP Trial
Author(s): Harriette Van Spall , Roland RJ van Kimmenade Added: 1 year ago
ACC 25 - FRESH-UP shows liberal fluid intake did not result in a significant difference in health status compared to fluid restriction of 1500ml per day, but did result in a lower perceived thirst distress.Dr Harriette Van Spall (McMaster University, CA) sits down with Dr Roland Van Kimmenade (Radboud University Medical Center, Nijmegen, NL) to discuss the findings from the multi-center,… View more

Heart Failure
HFA 24 Late-Breaker Wrap Up with Dr Van Spall & Dr Petrie
Author(s): Harriette Van Spall , Mark Petrie Added: 1 year ago
HFA 2024 — Join experts, Dr Harriette Van Spall (McMaster University, CA) and Dr Mark Petrie (University of Glasgow, UK) for an insightful wrap up of the novel data presented at 2024's Heart Failure Congress.00:24 - STEP HFpEF Programme: Semaglutide 2.4 mg and NTproBNP in obesity-related HFpEF & Semaglutide therapy and diuretic use in obesity-related HFpEF02:20 - EMPACT-MI: The effect of… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
ESC 25: Day 3 Wrap-Up with Dr Alasnag and Dr Al-Shaibi
Author(s): Mirvat Alasnag , Khaled Al-Shaibi Added: 7 months ago
ESC Congress 2025 – Day 3 of ESC Congress 2025 continued to deliver groundbreaking research with pivotal studies shaping the future of cardiovascular medicine.Interventional cardiologists Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (King Fahd Armed Forces Hospital, SA) provide their comprehensive breakdown of the most impactful hot line trial results from the day's sessions.Day 3 Highlights… View more
ESC 25: Day 2 Wrap-Up with Dr Alasnag and Dr Al-Shaibi
Author(s): Mirvat Alasnag , Khaled Al-Shaibi Added: 7 months ago
ESC Congress 2025 – The second day of ESC Congress 2025 brought forth significant findings with major implications for cardiovascular care.Interventional specialists Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (King Fahd Armed Forces Hospital, SA) share their expert analysis of the essential insights from the day's hot line trial presentations.Day 2 Highlights:MAPLE-HCMODYSSEY-HCMBETAMI… View more

Intervention

Heart Failure